Rigosertib + Azacitidine in Patients With Higher-Risk MDS

Slideset - Data from this small study suggest rigosertib plus azacitidine therapy may be effective and safe in this setting.

Source: Clinical Care Options Leukemia - December 14, 2015 Category: Hematology Source Type: research